Warburg’s $239m health deal progresses

Lifecore Biomedical has ended its go-shop period after discussions with more than 50 alternate partners.

4 January 2013•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.